UNH

516.88

-0.82%↓

NVO

135.68

+1.31%↑

JNJ

149.61

-2.5%↓

ABBV

158.36

-0.72%↓

MRK

131.09

+0.02%↑

UNH

516.88

-0.82%↓

NVO

135.68

+1.31%↑

JNJ

149.61

-2.5%↓

ABBV

158.36

-0.72%↓

MRK

131.09

+0.02%↑

UNH

516.88

-0.82%↓

NVO

135.68

+1.31%↑

JNJ

149.61

-2.5%↓

ABBV

158.36

-0.72%↓

MRK

131.09

+0.02%↑

UNH

516.88

-0.82%↓

NVO

135.68

+1.31%↑

JNJ

149.61

-2.5%↓

ABBV

158.36

-0.72%↓

MRK

131.09

+0.02%↑

UNH

516.88

-0.82%↓

NVO

135.68

+1.31%↑

JNJ

149.61

-2.5%↓

ABBV

158.36

-0.72%↓

MRK

131.09

+0.02%↑

Search

Eli Lilly and Co.

Closed

Sector Healthcare

807.28 0.75

Overview

Share price change

24h

Current

Min

801.02

Max

820.5

Key metrics

By Trading Economics

Income

2.2B

2.2B

Sales

-583M

8.8B

P/E

Sector Avg

105.456

23.904

EPS

2.58

Dividend yield

0.964

Profit margin

23.41

Employees

43,000

EBITDA

3.8B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+9.35 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.96%

7.76%

Next Earnings

8 Aug 2024

Next Dividend date

10 Jun 2024

Next Ex Dividend date

12 Aug 2024

Market Stats

By TradingEconomics

Market Cap

1.4B

738B

Previous open

806.53

Previous close

807.28

News Sentiment

By Acuity

27%

73%

51 / 370 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Eli Lilly and Co. Chart

Related News

9 May 2024, 12:00 UTC

Top News

Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled -- WSJ

3 May 2024, 21:33 UTC

Earnings

Amazon Stock Is on a Roll. Here's Why It's on This Firm's 'Best Ideas List.' -- Barrons.com

30 Apr 2024, 20:21 UTC

Earnings

These Stocks Moved the Most Today: MicroStrategy, Eli Lilly, 3M, PayPal, GE Healthcare, F5, Tesla, Chegg, Super Micro, and More -- Barrons.com

30 Apr 2024, 18:24 UTC

Earnings

These Stocks Are Moving the Most Today: MicroStrategy, Eli Lilly, 3M, PayPal, GE Healthcare, F5, Tesla, Chegg, Super Micro, and More -- Barrons.com

30 Apr 2024, 13:55 UTC

Hot Stocks

Stocks to Watch Tuesday: PayPal, Eli Lilly, 3M, McDonald's -- WSJ

30 Apr 2024, 13:19 UTC

Earnings

Eli Lilly Stock Jumps After Earnings Beat. Weight-Loss Drugs Are Driving Gains. -- Barrons.com

30 Apr 2024, 11:44 UTC

Earnings

Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound Sales Easily Beat -- IBD

30 Apr 2024, 11:08 UTC

Earnings

Eli Lilly Stock Jumps After Earnings Beat. Weight-Loss Drugs Are Driving Gains. -- Barrons.com

30 Apr 2024, 11:02 UTC

Earnings

Eli Lilly's Stock Jumps As First-Quarter Profit Tops Estimates Amid Strong Sales Of Mounjaro, Zepbound -- MarketWatch

30 Apr 2024, 10:47 UTC

Earnings

Eli Lilly Sees 2024 EPS $13.05-EPS $13.55 >LLY

30 Apr 2024, 10:47 UTC

Earnings

Eli Lilly Sees 2024 Adj EPS $13.50-Adj EPS $14.00 >LLY

30 Apr 2024, 10:46 UTC

Earnings

Eli Lilly: Raised Revenue View Reflects Strong Performance of Mounjaro, Zepbound, Greater Visibility Into Production Expansion >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly Raises Full-Year Revenue Guidance by $2 Billion >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Humalog Rev $538.7M >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Jardiance Rev $686.5M >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Trulicity Rev $1.46B >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Adj EPS $2.58 >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q EPS $2.48 >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Net $2.24B >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly Sees FY Rev $42.4B-$43.6B >LLY

30 Apr 2024, 10:45 UTC

Earnings

Eli Lilly 1Q Rev $8.77B >LLY

30 Apr 2024, 09:14 UTC

Hot Stocks

Stocks to Watch Tuesday: Stellantis, HSBC, Coca-Cola -- WSJ

26 Apr 2024, 20:09 UTC

Earnings

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed -- IBD

25 Apr 2024, 12:31 UTC

Acquisitions, Mergers, Takeovers

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market -- IBD

4 Apr 2024, 05:00 UTC

Top News

Big Pharma Stocks Need a Rethink. Investors Keep -2-

4 Apr 2024, 05:00 UTC

Top News

Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake. -- Barrons.com

2 Apr 2024, 12:51 UTC

Earnings

Eli Lilly's Ozempic Competitors Face Risks. Why the Stock Has More Upside. -- Barrons.com

23 Mar 2024, 13:00 UTC

Top News

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

21 Mar 2024, 14:59 UTC

Top News

Medicare Opens Door for Covering Obesity Drugs -- Update

19 Mar 2024, 20:03 UTC

Acquisitions, Mergers, Takeovers

Fusion Rockets 97%, As Radiopharmaceuticals Space Sparks On $2 Billion AstraZeneca Takeover -- IBD

Peer Comparison

Price change

Eli Lilly and Co. Forecast

Price Target

By TipRanks

9.35% upside

12 Months Forecast

Average 884.06 USD  9.35%

High 1,001 USD

Low 740 USD

Based on 21 Wall Street analysts offering 12 month price targets forEli Lilly and Co. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

21 ratings

18

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

769.2 / 816.61Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

No Evidence

Sentiment

By Acuity

51 / 370 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Eli Lilly and Co.

Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.